Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication.
|
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy.
|
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
7sNQgxsTXCQ03naQ